Pub. Date : 2017 Jan
PMID : 27849399
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Expert opinion: Based on favorable data from preclinical and clinical trials, regorafenib, c-Met inhibitor, and checkpoint inhibitors are promising agents for HCC after sorafenib failure. | Sorafenib | MET proto-oncogene, receptor tyrosine kinase | Homo sapiens |